`
`By: Daniel R. Evans
`Registration No. 55,868
`MERCHANT & GOULD P.C.
`191 Peachtree Street, NE
`Suite 3800
`Atlanta, GA 30303
`Main Telephone: 404.954.5100
`Main Facsimile: 612.332.9081
`
`
`
`Case No. IPR2017-01592
`U.S. Patent No. 8,410,131
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE
`
`PATENT TRIAL AND APPEAL BOARD
`
`BRECKENRIDGEG PHARMACEUTICAL, INC.
`
`Petitioner, v.
`
`NOVARTIS PHARMACEUTICALS CORPORATION
`
`Patent Owner.
`
`Case: IPR2017-01592
`U.S. Patent No. 8,410,131
`
`
`
`
`
`
`NOTICE OF JOINT STIPULATION TO
`MODIFY TRIAL DUE DATE 2
`
`
`IPR2018-00507 has been joined to this proceeding (Paper 29, Apr. 03, 2018)
`1
`
`
`
`Case No. IPR2017-01592
`U.S. Patent No. 8,410,131
`
`
`
`
`Pursuant to the Board’s authorization in the January 3, 2018 Scheduling
`
`
`
`
`
`Order (Paper 13 at 2), Petitioner Breckenridge Pharmaceutical, Inc. (“Petitioner”)
`
`hereby provides notice to the Board that Petitioner and Patent Owner Novartis
`
`Pharmaceuticals Corporation (“Patent Owner”) have stipulated to modify DUE
`
`DATE 2 as follows: DUE DATE 2 (currently set for June 20, 2018) is extended
`
`by less than half a day, specifically Patent Owner has agreed that Petitioner may
`
`file its Reply to Patent Owner’s Response to Petition and supporting Declaration of
`
`Allan J. Pantuck, Ph.D. by 10:00 AM ET on June 21, 2018. In addition, Petitioner
`
`and Patent Owner have agreed that service via email of Petitioner’s Reply to Patent
`
`Owner’s Response to Petition and supporting Declaration of Allan J. Pantuck,
`
`Ph.D. will be made by 8 AM ET on June 21, 2018. Petitioner’s Updated Exhibit
`
`List and other exhibits will be timely filed on June 20, 2018.
`
`
`
`
`
`2
`
`
`
`Patent Owner and Petitioner agree that all other DUE DATES in the
`
`Case No. IPR2017-01592
`U.S. Patent No. 8,410,131
`
`
`Scheduling Order remain the same.
`
`
`
`
`
`Dated: June 20, 2018
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`
`
`
`
`
`
`
`
`By: /Daniel R. Evans/
`Daniel R. Evans, Reg. No. 55,868
`MERCHANT & GOULD P.C.
`191 Peachtree Street, NE, Suite 3800
`Atlanta, GA 30303
`Main Telephone: 404.954.5100
`Main Facsimile: 612.332.9081
`
`Counsel for Petitioner Breckenridge
`Pharmaceutical, Inc.
`
`3
`
`
`
`Case No. IPR2017-01592
`U.S. Patent No. 8,410,131
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that the foregoing Notice of Joint
`
`
`
`
`
`Stipulation to Modify Trial Due Date 2 was served on June 20, 2018, upon the
`
`following parties via email:
`
`Nicholas N. Kallas
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`New York, NY 10104-2100
`NKallas@fchs.com
`ZortressAfinitorIPR@fchs.com
`
`I further certify that a copy of the foregoing Notice of Joint Stipulation to Modify
`
`Trial Date 2 was served on June 20, 2018, via email on counsel for Petitioner
`
`West-Ward Pharmaceuticals International Limited in Inter Partes Review No.
`
`2018-00507 at the following email addresses:
`
`Keith A. Zullow (kzullow@goodwinprocter.com)
`Marta E. Delsignore (mdelsignore@goodwinprocter.com)
`
`
`
`June 20, 2018
`
`
`By: /Daniel R. Evans/
`Daniel R. Evans, Reg. No. 55,868
`MERCHANT & GOULD P.C.
`191 Peachtree Street, NE, Suite 3800
`Atlanta, GA 30303
`Main Telephone: 404.954.5100
`Main Facsimile: 612.332.9081
`
`Counsel for Petitioner Breckenridge
`Pharmaceutical, Inc.
`4
`
`